Geneos Wealth Management’s ProShares Short S&P500 SH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.92K | Hold |
58
| – | – | ﹤0.01% | 2332 |
|
|
2026
Q1 | $2.2K | Hold |
58
| – | – | ﹤0.01% | 2302 |
|
|
2025
Q4 | $2.09K | Hold |
58
| – | – | ﹤0.01% | 2311 |
|
|
2025
Q3 | $2.14K | Hold |
58
| – | – | ﹤0.01% | 2308 |
|
|
2025
Q2 | $2.3K | Hold |
58
| – | – | ﹤0.01% | 2779 |
|
|
2025
Q1 | $2.58K | Hold |
58
| – | – | ﹤0.01% | 2696 |
|
|
2024
Q4 | $2.46K | Sell |
58
-1
| -2% | -$43 | ﹤0.01% | 2547 |
|
|
2024
Q3 | $2.57K | Hold |
59
| – | – | ﹤0.01% | 2238 |
|
|
2024
Q2 | $2.7K | Hold |
59
| – | – | ﹤0.01% | 1831 |
|
|
2024
Q1 | $2.81K | Hold |
59
| – | – | ﹤0.01% | 1826 |
|
|
2023
Q4 | $3.08K | Hold |
59
| – | – | ﹤0.01% | 1842 |
|
|
2023
Q3 | $3.43K | Hold |
59
| – | – | ﹤0.01% | 1837 |
|
|
2023
Q2 | $3.29K | Sell |
59
-2,642
| -98% | -$156K | ﹤0.01% | 1839 |
|
|
2023
Q1 | $162K | Hold |
2,701
| – | – | 0.01% | 707 |
|
|
2022
Q4 | $173K | Buy |
2,701
+375
| +16% | +$24K | 0.01% | 668 |
|
|
2022
Q3 | $160K | Buy |
2,326
+1,842
| +381% | +$115K | 0.01% | 667 |
|
|
2022
Q2 | $31K | Buy |
484
+375
| +344% | +$23.2K | ﹤0.01% | 1485 |
|
|
2022
Q1 | $6K | Sell |
109
-2,500
| -96% | -$144K | ﹤0.01% | 2292 |
|
|
2021
Q4 | $142K | Sell |
2,609
-75
| -3% | -$4.26K | 0.01% | 1035 |
|
|
2021
Q3 | $161K | Buy |
2,684
+750
| +39% | +$44.7K | 0.01% | 954 |
|
|
2021
Q2 | $117K | Sell |
1,934
-339
| -15% | -$21.5K | ﹤0.01% | 1105 |
|
|
2021
Q1 | $144K | Hold |
2,273
| – | – | ﹤0.01% | 1127 |
|
|
2020
Q4 | $134K | Sell |
2,273
-287
| -11% | -$21.9K | 0.01% | 1007 |
|
|
2020
Q3 | $212K | Sell |
2,560
-38
| -1% | -$3.15K | 0.01% | 674 |
|
|
2020
Q2 | $239K | Buy |
2,598
+2,288
| +738% | +$220K | 0.01% | 613 |
|
|
2020
Q1 | $35K | Sell |
310
-74
| -19% | -$7.47K | ﹤0.01% | 1262 |
|
|
2019
Q4 | $51K | Sell |
384
-124
| -24% | -$12.5K | ﹤0.01% | 1248 |
|
|
2019
Q3 | $53K | Buy |
508
+1
| +0.2% | +$106 | ﹤0.01% | 1148 |
|
|
2019
Q2 | $53K | Buy |
507
+200
| +65% | +$21.8K | ﹤0.01% | 1153 |
|
|
2019
Q1 | $33K | Sell |
307
-74
| -19% | -$8.56K | ﹤0.01% | 1350 |
|
|
2018
Q4 | $48K | Buy |
381
+76
| +25% | +$8.95K | ﹤0.01% | 1117 |
|
|
2018
Q3 | $33K | Hold |
305
| – | – | ﹤0.01% | 1363 |
|
|
2018
Q2 | $35K | Buy |
305
+1
| +0.3% | +$118 | ﹤0.01% | 1212 |
|
|
2018
Q1 | $36K | Hold |
304
| – | – | ﹤0.01% | 1150 |
|
|
2017
Q4 | $36K | Sell |
304
-63
| -17% | -$7.83K | ﹤0.01% | 1153 |
|
|
2017
Q3 | $47K | Sell |
367
-235
| -39% | -$30.9K | ﹤0.01% | 977 |
|
|
2017
Q2 | $80K | Buy |
602
+235
| +64% | +$31.9K | 0.01% | 753 |
|
|
2017
Q1 | $50K | Hold |
367
| – | – | 0.01% | 887 |
|
|
2016
Q4 | $53K | Sell |
367
-250
| -41% | -$37.6K | 0.01% | 815 |
|
|
2016
Q3 | $93K | Buy |
617
+295
| +92% | +$45.2K | 0.01% | 625 |
|
|
2016
Q2 | $50K | Buy |
+322
| New | +$52K | 0.01% | 812 |
|
Other funds holding SH
SFM
SWA
AWM
JF
DS
GWANC
Geneos Wealth Management's SH Position: Q2 2026 in Review
Geneos Wealth Management held its ProShares Short S&P500 (SH) position steady in Q2 2026 at 58 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2332.
Geneos Wealth Management first reported a position in SH in Q2 2016 and has held it in 41 quarters since. The position peaked at $239K in Q2 2020. 116 funds tracked by Wall St. Rank hold SH as of Q2 2026.
- Geneos Wealth Management held 58 shares of ProShares Short S&P500 worth $1.92K as of Q2 2026.
- Geneos Wealth Management left its ProShares Short S&P500 share count unchanged in Q2 2026.
- ProShares Short S&P500 made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2332 holding.
- Geneos Wealth Management first reported a position in ProShares Short S&P500 in Q2 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's ProShares Short S&P500 position peaked at $239K in Q2 2020.
- 116 funds tracked by Wall St. Rank held ProShares Short S&P500 as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.